Page 5 - Agenus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Agenus (NASDAQ:AGEN – Get Free Report) and Immunocore (NASDAQ:IMCR – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, risk, institutional ownership, profitability, valuation and earnings. Analyst Recommendations This is a breakdown of current recommendations and […]

Genus plc (LON:GNS – Get Free Report)’s stock price hit a new 52-week low during trading on Thursday . The stock traded as low as GBX 2,084 ($26.32) and last traded at GBX 2,100 ($26.52), with a volume of 11127 shares changing hands. The stock had previously closed at GBX 2,234 ($28.21). Wall Street Analyst […]

In the U.S. futures for the S&P 500 were down 0.3% and futures for the Dow Jones Industrial Average declined 0.2%. Changes in futures do not necessarily...

Agenus Inc. (NASDAQ:AGEN – Get Free Report) was the recipient of a large growth in short interest in August. As of August 15th, there was short interest totalling 26,320,000 shares, a growth of 36.2% from the July 31st total of 19,330,000 shares. Based on an average daily trading volume, of 5,290,000 shares, the days-to-cover ratio […]

RNS Announcements relating to Genus . All announcements from sources including RNS,PRN,BZW,NLK,CCN,CIS,HUG,AFX,TNS